HOUSTON, May 14 /PRNewswire-USNewswire/ -- A free resource designed to educate patients about ways to successfully manage their diabetes was revealed today at the American Association of Clinical Endocrinologists (AACE) 18th Annual Meeting & Clinical Congress.
The Power of Prevention(R) Magazine, is a patient-friendly quarterly publication published by the American College of Endocrinology (ACE), the scientific arm of AACE. The special "diabetes edition" of the magazine features articles written by experts in the treatment of the disease - endocrinologists.
Endocrinologists are doctors whose specialized training enables them to be experts in the care of endocrine disease, such as diabetes, thyroid disorders, growth hormone deficiency, osteoporosis, cholesterol disorders, hypertension and obesity.
"The Power of Prevention(R) initiative is designed to give patient's the tools and information to know what to ask for and what to expect from their health care providers during their visit," former president of the ACE Donald Bergman, MD, FACE, said. "The Power of Prevention Magazine is an integral part of that mission."
In the current issue, endocrinologists tackle topics ranging from prediabetes, the importance of weight management with type 2 diabetes and the changing face of diabetes management.
This edition of the magazine was made possible with the support of Novo Nordisk and the Changing Diabetes Leadership Initiative.
"Our shared passion for changing diabetes means we have to address the disease from multiple angles, from pursuing a cure to effective treatments to prevention and education," said Nathaniel Clark, MD, MS, RD, Senior Medical Advisor - Diabetes for Novo Nordisk. "The Power of Prevention(R) is an initiative that will give the power of education to the person at risk or with diabetes and we're proud to support it."
The Power of Prevention(R) Magazine, can be found in any local endocrinologist's office. An online version of the magazine is available for download on the AACE web site by clicking here.
AACE is a professional medical organization with more than 6,200 members in the United States and 92 other countries. Founded in 1991, AACE is dedicated to the optimal care of patients with endocrine problems. AACE initiatives inform the public about endocrine disorders. AACE also conducts continuing education programs for clinical endocrinologists, physicians whose advanced, specialized training enables them to be experts in the care of endocrine disease, such as diabetes, thyroid disorders, growth hormone deficiency, osteoporosis, cholesterol disorders, hypertension and obesity.
About Novo Nordisk
Novo Nordisk is a healthcare company with an 86-year history of innovation and achievement in diabetes care. The company has the broadest diabetes product portfolio in the industry, including the most advanced products within the area of insulin delivery systems. In addition to diabetes care, Novo Nordisk has a leading position within areas such as hemostasis management, growth hormone therapy, and hormone therapy for women. Novo Nordisk's business is driven by the Triple Bottom Line: a commitment to social responsibility to employees and customers, environmental soundness and economic success. With headquarters in Denmark, Novo Nordisk employs more than 27,000 employees in 81 countries, and markets its products in 179 countries. Novo Nordisk's B shares are listed on the stock exchanges in Copenhagen and London. Its ADRs are listed on the New York Stock Exchange under the symbol 'NVO'. For global information, visit novonordisk.com; for United States information, visit novonordisk-us.com.
|SOURCE American Association of Clinical Endocrinologists|
Copyright©2009 PR Newswire.
All rights reserved